A detailed history of Ctc LLC transactions in Pfizer Inc stock. As of the latest transaction made, Ctc LLC holds 167 shares of PFE stock, worth $4,164. This represents 0.0% of its overall portfolio holdings.

Number of Shares
167
Previous 690 75.8%
Holding current value
$4,164
Previous $19,000 78.95%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$27.7 - $31.39 $2.13 Million - $2.42 Million
-76,974 Reduced 28.17%
196,229 $5.68 Million
Q2 2024

Aug 09, 2024

SELL
$25.26 - $29.6 $3.08 Million - $3.61 Million
-121,813 Reduced 30.84%
273,203 $7.64 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $4.74 Million - $5.45 Million
-183,203 Reduced 31.68%
395,016 $11 Million
Q4 2023

Feb 06, 2024

BUY
$26.13 - $33.94 $7.59 Million - $9.86 Million
290,493 Added 100.96%
578,219 $16.6 Million
Q3 2023

Oct 31, 2023

SELL
$32.09 - $37.51 $3.61 Million - $4.22 Million
-112,407 Reduced 28.09%
287,726 $9.54 Million
Q2 2023

Aug 04, 2023

BUY
$36.12 - $41.79 $13.8 Million - $15.9 Million
381,613 Added 2060.55%
400,133 $14.7 Million
Q1 2023

May 22, 2023

BUY
$39.39 - $51.28 $729,502 - $949,705
18,520 New
18,520 $755,000
Q2 2022

Jul 07, 2022

SELL
$46.53 - $55.17 $9.28 Million - $11 Million
-199,343 Reduced 50.6%
194,629 $10.2 Million
Q1 2022

May 09, 2022

SELL
$45.75 - $56.69 $44.4 Million - $55 Million
-971,054 Reduced 71.14%
393,972 $20.4 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $33.6 Million - $49.9 Million
813,977 Added 147.71%
1,365,026 $80.6 Million
Q3 2021

Nov 16, 2021

SELL
$39.25 - $50.42 $21.6 Million - $27.8 Million
-551,049 Reduced 50.0%
551,049 $23.7 Million
Q3 2021

Oct 19, 2021

BUY
$39.25 - $50.42 $43.3 Million - $55.6 Million
1,102,098 New
1,102,098 $47.4 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ctc LLC Portfolio

Follow Ctc LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ctc LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ctc LLC with notifications on news.